Latest News

Novo Holdings co-leads €40m Qure.ai financing

CT scan. © Mitrey/pixabay.com


by tg

Deep learning medical imaging specialist Qure.ai raises $40m from healthcare investors Novo Holdings and HealthQuad 

Qure.ai said it will use the proceeds from the $40m financing round to intesify product development for  critical care and community diagnostics application and to expand marketing of its medical imaging diagnostics. The funding round was co-led by Novo Holdings and HealthQuad, with existing investor MassMutual Ventures participating.

Qure.ai's automated self-learning medical imaging tools that require only 1 min to evaluate X-ray, CT and ultrasound images can shorten the time to diagnosis while enabling physicians to triage medical cases more effectively, especially in time-sensitive situations. In other settings, where adequate, skilled specialists may not be available, Qure's technology is used as the first level of screening for many infections and non-communicable conditions.

Existing investors include Fractal analytics and Sequoia Capital.

mRNA for Africa

The plant is expected to have the capacity to fill and package 500 million doses annually. German competitor BioNTech SE has also announced plans to...

Evotec and BMS intensify R&D on protein degraders

AXA launches €440 m private equity healthcare strategy

The Strategy focuses specifically on companies in four core areas: medical devices, biopharmaceuticals, vaccines, and diagnostics. The...

Mimetas BV participating in €325m cancer funding

As part of a financing of the Dutch Naional Growth Fund the Oncode-PACT (Preclinical Accelerator for Cancer Treatments) initiative has been granted...

Study shows advantages of cellular agriculture

Replacing animal-source foods (ASFs) with novel or future foods (NFFs) – such as cultured milk, insect meal or mycoprotein – or plant-based...

Scientists print 3D cancer model

Using a bio-ink made from alginate and human cells, researchers at the Technical University of Berlin have 3D printed a model of a cancer metastasis...

Precirix NV raises €80m in Series B financing

The Series B financing round was led by led new investors INKEF Capital, Jeito Capital and Forbion. “The investment will allow Precirix to accelerate...